Ontology highlight
ABSTRACT:
SUBMITTER: Petkov VI
PROVIDER: S-EPMC5515329 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
Petkov Valentina I VI Miller Dave P DP Howlader Nadia N Gliner Nathan N Howe Will W Schussler Nicola N Cronin Kathleen K Baehner Frederick L FL Cress Rosemary R Deapen Dennis D Glaser Sally L SL Hernandez Brenda Y BY Lynch Charles F CF Mueller Lloyd L Schwartz Ann G AG Schwartz Stephen M SM Stroup Antoinette A Sweeney Carol C Tucker Thomas C TC Ward Kevin C KC Wiggins Charles C Wu Xiao-Cheng XC Penberthy Lynne L Shak Steven S
NPJ breast cancer 20160608
The 21-gene Recurrence Score assay is validated to predict recurrence risk and chemotherapy benefit in hormone-receptor-positive (HR+) invasive breast cancer. To determine prospective breast-cancer-specific mortality (BCSM) outcomes by baseline Recurrence Score results and clinical covariates, the National Cancer Institute collaborated with Genomic Health and 14 population-based registries in the the Surveillance, Epidemiology, and End Results (SEER) Program to electronically supplement cancer s ...[more]